U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07167511) titled 'Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication' on Aug. 25.
Brief Summary: Bismuth-containing quadruple therapy was recommended as a first-line treatment for Helicobacter pylori infection. This study aimed to compare real-world outcomes of various bismuth-containging quadruple regimens and identify factors influencing treatment failure. A multicenter retrospective analysis was conducted and study outcomes included eradication rates and incidence of adverse events.
Study Start Date: Jan. 01, 2022
Study Type: OBSERVATIONAL
Condition:
Helicobacter Pylori Infection
Intervention:
OTHER: This study is a re...